Inidication

2018-05-17 17:20:05 0

XW002  Treatment of diabetes and obesity , IND has been filed, and will be starting clinical trials in ----------2019.

XW003  Treatment of NASH and liver fibrosis, Currently under CMC phase, IND is expected to be ----------filed by the end-of 2019.

XW004  Treatment of NASH and liver fibrosis, Unique form of oral  ,Currently under CMC phase and ----------drug safety assessment, IND is expected to be filed by the end of 2019,and is ready ----------for clinical trials in China and the United States.

XW005 Treatment of liver cirrhosis, Currently under R&D phase.

XW006 Treatment of liver cirrhosis, Currently under R&D phase.